Related Experiment Videos

Increased responsiveness to macrophage-activating factor (MAF) after alteration of macrophage membranes

Insights

Guinea pig macrophages pretreated with antithrombin III (AT III), an esterase inhibitor, showed enhanced tumor cell killing when exposed to macrophage-activating factor (MAF). Chemical modification of macrophage membranes can boost MAF activity.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Macrophage responsiveness to lymphocyte mediators is crucial for immune responses.
  • Macrophage-activating factor (MAF) is a key mediator in activating macrophages.
  • The precise mechanisms modulating MAF activity on macrophages are not fully understood.

Purpose of the Study:

  • To investigate whether chemical modification of the macrophage membrane can enhance responsiveness to MAF.
  • To determine if esterase inhibition influences MAF-mediated macrophage activation.
  • To explore the role of membrane-bound esterases in modulating macrophage activity.

Main Methods:

  • Guinea pig macrophages were pretreated with antithrombin III (AT III), an esterase inhibitor.
  • Macrophages were also incubated with diazotized sulfanilic acid (DSA), a cell surface reactant.
  • Enhanced cytotoxicity of MAF-treated macrophages against tumor cells was measured.

Main Results:

  • Pretreatment with AT III significantly enhanced MAF-induced macrophage cytotoxicity against tumor cells.
  • Proteins lacking esterase inhibitory properties did not enhance MAF activity.
  • Incubation with DSA also led to enhanced MAF activity, indicating chemical modification boosts MAF effects.

Conclusions:

  • Chemical modifications of the macrophage membrane can enhance MAF activity.
  • An esterase present on the macrophage membrane appears to modulate the cell's response to lymphocyte mediators like MAF.
  • These findings support the hypothesis of a membrane-bound esterase acting as a key regulator in macrophage activation.

Related Concept Videos